PHVS
Price
$24.16
Change
-$0.41 (-1.67%)
Updated
Sep 26 closing price
Capitalization
1.55B
37 days until earnings call
SNDX
Price
$15.68
Change
+$0.65 (+4.32%)
Updated
Sep 26 closing price
Capitalization
1.35B
43 days until earnings call
Interact to see
Advertisement

PHVS vs SNDX

Header iconPHVS vs SNDX Comparison
Open Charts PHVS vs SNDXBanner chart's image
Pharvaris
Price$24.16
Change-$0.41 (-1.67%)
Volume$81.48K
Capitalization1.55B
Syndax Pharmaceuticals
Price$15.68
Change+$0.65 (+4.32%)
Volume$2.92M
Capitalization1.35B
PHVS vs SNDX Comparison Chart in %
Loading...
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHVS vs. SNDX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHVS is a StrongBuy and SNDX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (PHVS: $24.17 vs. SNDX: $15.68)
Brand notoriety: PHVS and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHVS: 42% vs. SNDX: 122%
Market capitalization -- PHVS: $1.55B vs. SNDX: $1.35B
PHVS [@Biotechnology] is valued at $1.55B. SNDX’s [@Biotechnology] market capitalization is $1.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHVS’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • PHVS’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDX is a better buy in the long-term than PHVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHVS’s TA Score shows that 3 TA indicator(s) are bullish while SNDX’s TA Score has 5 bullish TA indicator(s).

  • PHVS’s TA Score: 3 bullish, 4 bearish.
  • SNDX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNDX is a better buy in the short-term than PHVS.

Price Growth

PHVS (@Biotechnology) experienced а -4.71% price change this week, while SNDX (@Biotechnology) price change was +6.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.96%. For the same industry, the average monthly price growth was +9.24%, and the average quarterly price growth was +51.43%.

Reported Earning Dates

PHVS is expected to report earnings on Nov 05, 2025.

SNDX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+3.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($1.55B) has a higher market cap than SNDX($1.35B). PHVS YTD gains are higher at: 26.056 vs. SNDX (18.608). PHVS has higher annual earnings (EBITDA): -165.21M vs. SNDX (-314.25M). SNDX has more cash in the bank: 469M vs. PHVS (200M). PHVS has less debt than SNDX: PHVS (634K) vs SNDX (1.68M). SNDX has higher revenues than PHVS: SNDX (77.9M) vs PHVS (0).
PHVSSNDXPHVS / SNDX
Capitalization1.55B1.35B115%
EBITDA-165.21M-314.25M53%
Gain YTD26.05618.608140%
P/E RatioN/AN/A-
Revenue077.9M-
Total Cash200M469M43%
Total Debt634K1.68M38%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PHVSSNDX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 13 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
PHVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JARSX14.980.13
+0.86%
Easterly Global Real Estate R6
CGEZX21.560.11
+0.51%
Columbia Select Global Equity Inst
FTGFX31.130.15
+0.48%
Templeton Growth R6
PGKAX30.240.10
+0.33%
PGIM Jennison Technology A
BGIKX14.88N/A
N/A
Baillie Gifford International Alpha K

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with NUVL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
-1.69%
NUVL - PHVS
34%
Loosely correlated
+4.99%
INKT - PHVS
34%
Loosely correlated
+2.57%
SNDX - PHVS
33%
Loosely correlated
+4.32%
MGTX - PHVS
33%
Loosely correlated
-0.12%
HOWL - PHVS
33%
Poorly correlated
+2.48%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with REPL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+4.32%
REPL - SNDX
51%
Loosely correlated
+1.98%
CGON - SNDX
50%
Loosely correlated
+2.91%
NRIX - SNDX
47%
Loosely correlated
+7.20%
NUVL - SNDX
47%
Loosely correlated
+4.99%
XENE - SNDX
47%
Loosely correlated
+4.00%
More